EUVIMEDEUVIMED entdecken
Crossref

Mikan-fermented tea enhanced hesperidin bioavailability: In vivo pharmacokinetic and in vitro Caco-2 Cell

Arata Banno, Yutaka Yoshino, Yuji Miyata, Hisayuki Nakayama, Toshiro Matsui

Journal of Food Bioactives · 2025-12 · 51-57

DOI: 10.26599/jfb.2025.95032432 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Food Bioactives, 2025-12. Verfasst von Arata Banno und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Banno, A., Yoshino, Y., Miyata, Y., Nakayama, H., & Matsui, T. (2025). Mikan-fermented tea enhanced hesperidin bioavailability: In vivo pharmacokinetic and in vitro Caco-2 Cell. Journal of Food Bioactives, 51-57. https://doi.org/10.26599/jfb.2025.95032432

Vancouver

Banno A, Yoshino Y, Miyata Y, Nakayama H, Matsui T. Mikan-fermented tea enhanced hesperidin bioavailability: In vivo pharmacokinetic and in vitro Caco-2 Cell. Journal of Food Bioactives. 2025:51-57. doi:10.26599/jfb.2025.95032432

BibTeX
@article{Banno2025,
  author = {Banno, Arata and Yoshino, Yutaka and Miyata, Yuji and Nakayama, Hisayuki and Matsui, Toshiro},
  title = {Mikan-fermented tea enhanced hesperidin bioavailability: In vivo pharmacokinetic and in vitro Caco-2 Cell},
  journal = {Journal of Food Bioactives},
  year = {2025},
  pages = {51--57},
  doi = {10.26599/jfb.2025.95032432}
}
Kostenlos starten →